Advertisement

Topics

Evaluate, Ltd. Company Profile

05:16 EDT 23rd September 2018 | BioPortfolio

Evaluate is the trusted source for life science market intelligence and analysis with exclusive consensus forecasts to 2020. Evaluate supports life science and healthcare companies, financial institutions, consultancies and service providers in their strategic decision-making. Its services include EvaluatePharma, EvaluateClinicalTrials and EvaluateMedTech. A global team of dedicated healthcare analysts employs rigorous methodologies to deliver strategic commercial analysis. Evaluate provides superior quality content, user-friendly reporting tools and outstanding customer service to solve industry problems. For more information visit: www.evaluategroup.com. On Twitter: @evaluatepharma, @evaluatemedtech, @epclinicaltrial.


News Articles [113 Associated News Articles listed on BioPortfolio]

Worldwide Prescription Drug Sales Accelerate To $1.2 Trillion By 2024, And Other Findings

NewsA preview of Evaluate's pharmaceutical industry outlook for the years to come. Contributed Author: 

CancerConnect Launches Survey To Evaluate Patient Use and Perceptions of Social Media

CancerConnect has launched an online market research survey to evaluate cancer patients use patterns and perceptions of social media. Social […] The post CancerConnect Launches Survey To Evaluat...

Genprex to enroll patients in study to evaluate anti-cancer agent Oncoprex with FDA-approved Erlotinib

The Phase 1/2 study will evaluate Oncoprex with erlotinib as a combination therapy for the treatment of non-small cell lung cancer

Apexigen and Yale Cancer Center Collaborate to Evaluate APX005M, Cabiralizumab, and Opdivo in Patients whose Disease has Progressed on Anti-PD-1/PD-L1 Therapy

San Carlos, CA, and New Haven, CT – June 14, 2018 – Apexigen, Inc., and Yale Cancer Center today announced a clinical trial collaboration to evaluate Apexigen’s APX005M in combination with cab...

EMA and FDA evaluate link between HIV drug and birth defects

The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) are separately investigating the preliminary results from...Read More... The post EMA and FDA evaluate link between HI...

Leap, Merck KGAA, and Pfizer evaluate solid tumor combo therapy

Leap Therapeutics Inc. has teamed up with partners Merck KGAA and Pfizer Inc. in a trial collaboration that will evaluate a new treatment combination regimen for advanced solid tumors.

Leap Therapeutics To Collaborate With Merck, Pfizer To Evaluate TRX518

NEW YORK CITY (dpa-AFX) - Leap Therapeutics, Inc. (LPTX) announced a collaboration agreement with Merck KGaA, and Pfizer to evaluate Leap's GITR agonist, TRX518, in combination with avelumab, a hu...

Pfizer to evaluate Atomwise’s platform to identify drug candidates for three target proteins

Pfizer will evaluate Atomwise’s platform to identify potential drug candidates for up to three target proteins selected by Pfizer. In the agreement, Pfizer will pay a technology access The post Pfi...

Drugs and Medications [0 Results]

None

PubMed Articles [99 Associated PubMed Articles listed on BioPortfolio]

Psychometric properties of a questionnaire (HEMO-FISS-QoL) to evaluate the burden associated with haemorrhoidal disease and anal fissures.

Current questionnaires designed to evaluate the haemorrhoidal disease burden ignore symptoms such as bleeding, pain and itching. A specific questionnaire is needed to evaluate the global impact of ana...

Is a blood sample for hemoglobins in the transfusional range reliable?

To evaluate the correlation and agreement in our unit and population of hemoglobin in gasometry versus hematology analyzer, to evaluate errors in transfusion or lack thereof.

The Impact of Specialization in Journal Networks and Scholarship.

The use of bibliometrics to evaluate authors, institutions, and journals faces significant challenges in comparing biomedical specialties because of marked differences among fields. Our objective was ...

The Anesthesia Perioperative "Call for Help"-Experience at a Quaternary Pediatric Medical Center: Analysis of 67,564 Anesthesia Encounters.

During the past several decades, anesthesia has become increasingly safe. Truly major adverse events are rare, and anesthesia quality researchers have instituted programs to evaluate "near miss" or le...

Relationship between knee joint contact forces and external knee joint moments in patients with medial knee osteoarthritis: Effects of gait modifications.

To evaluate i) the relationship between the knee contact force (KCF) and knee adduction and flexion moments (KAM and KFM) during normal gait in people with medial knee osteoarthritis (KOA), ii) to eva...

Clinical Trials [14 Associated Clinical Trials listed on BioPortfolio]

Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis

Primary Objective: To evaluate the efficacy of sarilumab at week 16 in patients with non-infectious uveitis (NIU). Secondary Objectives: To evaluate the change in best corre...

Safety and Efficacy of Isatuximab in Lymphoblastic Leukemia

Primary Objective: To evaluate the efficacy of isatuximab. Secondary Objectives: - To evaluate the safety profile of isatuximab. - To evaluate the duration of respons...

An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression

The purpose of the study is to evaluate the efficacy and safety of saredutant (or SR48968C) in patients with depression. The primary objective is to evaluate the efficacy of a 100 mg dose...

An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression

The purpose of the study is to evaluate the efficacy and safety of saredutant (or SR48968C) in patients with depression. The primary objective is to evaluate the efficacy of a 100 mg dose...

An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression

The purpose of the study is to evaluate the efficacy and safety of saredutant (or SR48968C) in patients with depression. The primary objective is to evaluate the efficacy of a 100 mg dose...

Companies [134 Associated Companies listed on BioPortfolio]

Evaluate, Ltd.

Evaluate is the trusted source for life science market intelligence and analysis with exclusive consensus forecasts to 2020. Evaluate supports life science and healthcare companie...

Evaluate Ltd.

Established in 1996, Evaluate Ltd. is the leader in high quality life science sector analysis. EvaluatePharma delivers exclusive consensus forecasts and trusted commercial insight...

ERT

Based in Philadelphia, PA, eResearchTechnology, Inc. (www.ert.com) is a global provider of technology and services to the pharmaceutical, biotechnology and medical device industries. The Company is a...

RMS

RMS models and software help financial institutions and public agencies evaluate and manage catastrophe risks throughout the world, promoting resilient societies and a sustainable...

Galant & Lin, M.D.’s Inc

Our goal is to provide a caring environment where we evaluate your allergy problems, and then establish a long-term relationship to ensure that you always receive the best, most comprehensive allergy ...

More Information about "Evaluate, Ltd." on BioPortfolio

We have published hundreds of Evaluate, Ltd. news stories on BioPortfolio along with dozens of Evaluate, Ltd. Clinical Trials and PubMed Articles about Evaluate, Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Evaluate, Ltd. Companies in our database. You can also find out about relevant Evaluate, Ltd. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record